FDA WARNING_LETTER - DrJockers.com, LLC - April 14, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Warning Letter, dated April 21, 2020, addresses Dr. Jockers for selling unapproved and misbranded products related to COVID-19. The FDA and FTC reviewed www.drjockers.com on March 19 and April 14, 2020, and social media sites, observing the sale of Super C, Vitamin D/K2, Zinc Charge, and ImmunoStrong Berry Liquid. These products are marketed with claims to mitigate, prevent, treat, diagnose, or cure COVID-19, such as "Take Vitamin C," "Optimize Vitamin D & Zinc," and "Use ElderBerry & Astragalus."
The FDA determined these products are unapproved new drugs, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), and misbranded drugs under section 502 (21 U.S.C. § 352). Their introduction into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)). The letter emphasizes the public health emergency declared for COVID-19.
Dr. Jockers is required to immediately cease selling these unapproved products and send an email to COVID-19-Task-Force-CFSAN@fda
ID · 74f5f5b2-0f71-46fb-943d-0de4dddbee5d
Full citation text and observation details available on the Dashboard.